The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Cardiomyopathy (acute, subacute, chronic)
Publications
Cardiomyopathy and heart failure secondary to anabolic-androgen steroid abuse.
Proceedings (Baylor University. Medical Center). 2022;35(3):363-365
Anabolic Steroid-induced Reversible Cardiomyopathy in a Young Non-athletic Female.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP. 2022;32(2):233-235
Forensic Post-Mortem Investigation in AAS Abusers: Investigative Diagnostic Protocol. A Systematic Review.
Diagnostics (Basel, Switzerland). 2021;11(8)
Sudden cardiac death in anabolic androgenic steroids abuse: case report and literature review.
Forensic sciences research. 2019;4(3):267-273
Non-ischemic Cardiomyopathy Secondary to Left Ventricular Hypertrophy due to Long-term Anabolic-androgenic Steroid Use in a Former Olympic Athlete.
Cureus. 2018;10(9):e3313
Cardiomyopathy induced by anabolic-androgenic steroid abuse.
BMJ case reports. 2018;2018
Anabolic androgenic steroids abuse and cardiac death in athletes: morphological and toxicological findings in four fatal cases.
Forensic science international. 2012;217(1-3):e13-8